- Filed
- Jul 24, 2015 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2015 · Jul 15, 2015 | 191.51M sh |
| Shares Diluted | Q2 2015 · Jun 30, 2015 | 192M sh |
| Shares Diluted | Q2 2015 · Jun 30, 2015 | 192M sh |
| Shares Diluted | Q2 2015 · Jun 30, 2014 | 205M sh |
| Shares Diluted | Q2 2015 · Jun 30, 2014 | 211M sh |
| Stock Repurchased | Q2 2015 · Jun 30, 2015 | $13M |
| Stock Repurchased | Q2 2015 · Jun 30, 2015 | $195M |
| Stock Repurchased | Q2 2015 · Jun 30, 2014 | $303M |
| Stock Repurchased | Q2 2015 · Jun 30, 2014 | $1.21B |
| Long Term Debt | Q2 2015 · Jun 30, 2015 | $2.81B |
| Long Term Debt | Q2 2015 · Dec 31, 2014 | $2.82B |
| Short Term Debt | Q2 2015 · Jun 30, 2015 | $31M |
| Short Term Debt | Q2 2015 · Dec 31, 2014 | $263M |
| Short Term Investments | Q2 2015 · Jun 30, 2015 | $436M |
| Short Term Investments | Q2 2015 · Dec 31, 2014 | $113M |
| Cash And Equivalents | Q2 2015 · Jun 30, 2015 | $1.3B |
| Cash And Equivalents | Q2 2015 · Mar 31, 2015 | $1.32B |
| Cash And Equivalents | Q2 2015 · Dec 31, 2014 | $1.51B |
| Cash And Equivalents | Q2 2015 · Jun 30, 2014 | $1.53B |
| Cash And Equivalents | Q2 2015 · Mar 31, 2014 | $972M |
| Cash And Equivalents | Q2 2015 · Dec 31, 2013 | $1.81B |
| Stockholders Equity | Q2 2015 · Jun 30, 2015 | $4.42B |
| Stockholders Equity | Q2 2015 · Dec 31, 2014 | $4.56B |
| Current Liabilities | Q2 2015 · Jun 30, 2015 | $3.26B |
| Current Liabilities | Q2 2015 · Dec 31, 2014 | $4.27B |
| Total Liabilities | Q2 2015 · Jun 30, 2015 | $6.42B |
| Total Liabilities | Q2 2015 · Dec 31, 2014 | $7.45B |
| Current Assets | Q2 2015 · Jun 30, 2015 | $7.16B |
| Current Assets | Q2 2015 · Dec 31, 2014 | $7.55B |
| Total Assets | Q2 2015 · Jun 30, 2015 | $11.73B |
| Total Assets | Q2 2015 · Dec 31, 2014 | $12.89B |
| Eps Diluted | Q2 2015 · Jun 30, 2015 | $0.73 |
| Eps Diluted | Q2 2015 · Jun 30, 2015 | $0.98 |
| Eps Diluted | Q2 2015 · Jun 30, 2014 | $1.08 |
| Eps Diluted restated | Q2 2015 · Jun 30, 2014 | $1.57 |
| Eps Basic | Q2 2015 · Jun 30, 2015 | $0.73 |
| Eps Basic | Q2 2015 · Jun 30, 2015 | $0.98 |
| Eps Basic | Q2 2015 · Jun 30, 2014 | $1.08 |
| Eps Basic | Q2 2015 · Jun 30, 2014 | $1.59 |
| Sga Expense | Q2 2015 · Jun 30, 2015 | $279M |
| Sga Expense | Q2 2015 · Jun 30, 2015 | $565M |
| Sga Expense restated | Q2 2015 · Jun 30, 2014 | $333M |
| Sga Expense restated | Q2 2015 · Jun 30, 2014 | $651M |
| Net Income | Q2 2015 · Jun 30, 2015 | $140M |
| Net Income | Q2 2015 · Jun 30, 2015 | $189M |
| Net Income | Q2 2015 · Jun 30, 2014 | $221M |
| Net Income | Q2 2015 · Jun 30, 2014 | $332M |
| Cost Of Revenue | Q2 2015 · Jun 30, 2015 | $1.59B |
| Cost Of Revenue | Q2 2015 · Jun 30, 2015 | $3.19B |
| Cost Of Revenue restated | Q2 2015 · Jun 30, 2014 | $1.85B |
| Cost Of Revenue restated | Q2 2015 · Jun 30, 2014 | $3.54B |